Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M225Revenue $M83.8Net Margin (%)-47.5Z-Score9.3
Enterprise Value $M149EPS $-1.6Operating Margin %-47.9F-Score5
P/E(ttm))0Cash Flow Per Share $-0.2Pre-tax Margin (%)-47.7Higher ROA y-yN
Price/Book1.810-y EBITDA Growth Rate %0Quick Ratio7.6Cash flow > EarningsY
Price/Sales2.65-y EBITDA Growth Rate %0Current Ratio8.8Lower Leverage y-yY
Price/Cash Flow0y-y EBITDA Growth Rate %0ROA % (ttm)-28.7Higher Current Ratio y-yY
Dividend Yield %0Insider Buy (3m)0ROE % (ttm)-31.4Less Shares Outstanding y-yY
Payout Ratio %0Shares Outstanding M25.7ROI % (ttm)-27.1Gross Margin Increase y-yN

Gurus Latest Trades with DSCI

Number of guru portfolios checked: 84. (List those with share number changes of more than 20%, or impact to portfolio more than 0.1%)

No Entry found!

DSCI is held by these Gurus:

Premium Most recent portfolio changes are included for Premium Members only!


DSCI: Insider Buys/Sells

Click Here for All Insider Trades.
InsiderPosition Date Trades Shares Trade Price ($) Change (%) Details
CONJEEVARAM SRINIDirector 2014-12-15Sell12,500$8.493.06view
STAFFORD C RICHARDDirector 2014-12-04Sell6,075$8.591.86view
STAFFORD C RICHARDDirector 2014-11-25Sell1,775$8.265.93view
STAFFORD C RICHARDDirector 2014-11-18Sell5,050$8.562.22view
STAFFORD C RICHARDDirector 2014-11-14Sell5,073$8.483.18view
Wolfenson BarrySee Remarks 2014-09-16Buy3,750$7.999.51view
Wolfenson BarrySee Remarks 2014-05-19Buy11,250$8.79-0.46view
QUILTY EDWARD JPresident & CEO 2014-05-16Buy10,000$8.70.57view
RA CAPITAL MANAGEMENT, LLC 2014-01-10Sell300,000$11.83-26.04view
STAFFORD C RICHARDDirector 2013-09-03Sell15,000$14.06-37.77view

Press Releases about DSCI :

    Quarterly/Annual Reports about DSCI:

    News about DSCI:

    Articles On GuruFocus.com
    Derma Sciences Inc. Reports Operating Results (10-Q) Nov 12 2010 
    Derma Sciences Inc. Reports Operating Results (10-Q) May 12 2010 

    More From Other Websites
    Broadfin Buffs Up on Zogenix, Inc. (ZGNX) and Derma Sciences Inc (DSCI) Mar 19 2015
    DERMA SCIENCES, INC. Financials Mar 18 2015
    Derma Sciences Inc Earnings Call scheduled for 11:00 am ET today Mar 12 2015
    Derma Sciences reports 4Q loss Mar 12 2015
    Derma Sciences reports 4Q loss Mar 12 2015
    Derma Sciences Reports Fourth Quarter and Year Ended Financial Results Mar 12 2015
    Derma Sciences Reports Fourth Quarter and Year Ended Financial Results Mar 12 2015
    Q4 2014 Derma Sciences Inc Earnings Release - Time Not Supplied Mar 12 2015
    DERMA SCIENCES, INC. Files SEC form 10-K, Annual Report Mar 11 2015
    Derma Sciences Names Pharmaceutical Development Leader John Caminis, M.D. as Chief Medical Officer Mar 09 2015
    Derma Sciences Names Pharmaceutical Development Leader John Caminis, M.D. as Chief Medical Officer Mar 09 2015
    Derma Sciences to Hold Fourth Quarter Financial Results Conference Call on March 12th Mar 04 2015
    Derma Sciences to Hold Fourth Quarter Financial Results Conference Call on March 12th Mar 04 2015
    Derma Sciences to Present at the 27th Annual Roth Conference Mar 04 2015
    Derma Sciences to Present at the 27th Annual Roth Conference Mar 04 2015
    Connecture Inc (CNXR), Hyperion Therapeutics Inc (HPTX): Top 5 Healthcare Picks of Great Point... Mar 02 2015
    Derma Sciences Expands Access of its AMNIOTIC TISSUE Product Line with New Premier, Inc. Agreement Jan 22 2015
    Derma Sciences Expands Access of its AMNIOTIC TISSUE Product Line with New Premier, Inc. Agreement Jan 22 2015
    Derma Sciences Introduces 2015 Financial Guidance and Provides 2014 Preliminary Net Sales Jan 08 2015
    Derma Sciences Introduces 2015 Financial Guidance and Provides 2014 Preliminary Net Sales Jan 08 2015

    Add Notes, Comments

    If you want to ask a question, or report a bug, please create a support ticket.

    User Comments

    No comment yet
    Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
    GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
    Free 7-day Trial
    FEEDBACK